RLYB-116
- Generic Name
- RLYB-116
Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration
- First Posted Date
- 2014-03-11
- Last Posted Date
- 2015-07-28
- Lead Sponsor
- Swedish Orphan Biovitrum
- Target Recruit Count
- 24
- Registration Number
- NCT02083666
- Locations
- 🇬🇧
Richmond Pharmacology Ltd., London, St George's University of London, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath